Roger Jeffs Sells 18,839 Shares of Liquidia (NASDAQ:LQDA) Stock

Liquidia Corporation (NASDAQ:LQDA) CEO Roger Jeffs sold 18,839 shares of the stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $40.60, for a total transaction of $764,863.40. Following the transaction, the chief executive officer directly owned 1,423,095 shares of the company’s stock, valued at $57,777,657. This represents a 1.31% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Roger Jeffs also recently made the following trade(s):

• On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.14, for a total transaction of $1,003,500.00.
• On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The stock was sold at an average price of $40.00, for a total transaction of $132,000.00.
• On Monday, April 13th, Roger Jeffs sold 32,744 shares of Liquidia stock. The stock was sold at an average price of $38.37, for a total transaction of $1,256,387.28.
• On Friday, April 10th, Roger Jeffs sold 21,433 shares of Liquidia stock. The stock was sold at an average price of $40.12, for a total transaction of $859,891.96.
• On Thursday, April 9th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.12, for a total transaction of $1,003,000.00.

Liquidia Trading Up 2.2%

NASDAQ LQDA opened at $37.06 on Thursday. The stock has a market capitalization of $3.27 billion, a P/E ratio of -44.65 and a beta of 0.45. Liquidia Corporation has a 52-week low of $11.85 and a 52-week high of $46.67. The firm has a 50-day moving average price of $36.31 and a 200 day moving average price of $33.64. The company has a quick ratio of 1.84, a current ratio of 2.01 and a debt-to-equity ratio of 2.97.

Liquidia (NASDAQ:LQDA) last posted its quarterly earnings results on Thursday, March 5th. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.08 by $0.07. The firm had revenue of $92.02 million during the quarter, compared to analysts’ expectations of $87.49 million. Liquidia had a negative net margin of 43.53% and a negative return on equity of 209.33%. The firm’s quarterly revenue was up 3072.4% compared to the same quarter last year. Equities research analysts expect that Liquidia Corporation will post 1.75 EPS for the current year.

Analyst Ratings Changes

LQDA has been the subject of a number of research analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Liquidia in a report on Thursday, January 22nd. Zacks Research cut shares of Liquidia from a “strong-buy” rating to a “hold” rating in a report on Friday, February 27th. Wells Fargo & Company increased their target price on shares of Liquidia from $44.00 to $51.00 and gave the company an “overweight” rating in a report on Monday, March 23rd. Oppenheimer increased their target price on shares of Liquidia from $16.00 to $19.00 and gave the company an “underperform” rating in a report on Thursday, March 12th. Finally, BTIG Research increased their target price on shares of Liquidia from $49.00 to $50.00 and gave the company a “buy” rating in a report on Thursday, March 5th. Two research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $43.44.

Institutional Trading of Liquidia

Large investors have recently modified their holdings of the business. Federated Hermes Inc. acquired a new stake in shares of Liquidia in the third quarter valued at approximately $7,290,000. Caprock Group LLC acquired a new stake in shares of Liquidia in the third quarter valued at approximately $37,114,000. Farallon Capital Management LLC grew its position in shares of Liquidia by 102.1% in the third quarter. Farallon Capital Management LLC now owns 8,565,638 shares of the company’s stock valued at $194,783,000 after purchasing an additional 4,326,876 shares during the last quarter. Apis Capital Advisors LLC acquired a new stake in shares of Liquidia in the third quarter valued at approximately $9,569,000. Finally, Campbell & CO Investment Adviser LLC acquired a new stake in shares of Liquidia in the third quarter valued at approximately $2,026,000. 64.54% of the stock is currently owned by institutional investors and hedge funds.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).